ZURICH: Novartis wants every puff of its emphysema drug Onbrez to go into the cloud.
The Swiss drugmaker has teamed up with US technology firm Qualcomm to develop an Internet-connected inhaler that can send information about how often it is used to remote computer servers known as the cloud.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!